Final Results for the year ended 30 June 2015

Chairman’s Statement

 Summary of Results in the year ended 30 June 2015

•    The turnover of the Company was £235,486 (2014: £267,903).

•    The operating loss reduced to £414,755 (2014: £465,265).

•    On 30 June 2015 the surplus of shareholders’ funds was £325,617 (2014: £136,487).

This year, Physiomics extended its product range and made a key commercial breakthrough, signing its first long term Virtual Tumour Clinical deal with a large pharmaceutical company.

In summary we have:

})(jQuery)